TG Therapeutics (TGTX) total liabilities

Total liabilities · fiscal 2025
$415.23M

TG Therapeutics (TGTX) had total liabilities of $415.23M at the end of fiscal 2025 (December 31, 2025). That is 16.9% higher than the $355.33M of fiscal 2024. Figures as of 19 Nov 2026, 11:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$415.23M
Change on fiscal 2024
+16.9%
Growth, 5 years
+31.3% a year
Growth, 10 years
+42.7% a year
Highest on record
$415.23Mfiscal 2025
Lowest on record
$4.90Mfiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

TG Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 31.3% a year; over ten years the rate was 42.7% a year. Across the 15 fiscal years on record (2011–2025), the highest was $415.23M in fiscal 2025 and the lowest $4.90M in fiscal 2011.

History · 15 fiscal years

Total liabilities by fiscal year

TG Therapeutics total liabilities, year by year

TG Therapeutics (TGTX) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$415.23M 16.9% up
2024$355.33M 110.1% up
2023$169.09M 25.3% up
2022$134.99M 5.3% down
2021$142.48M 34.0% up
2020$106.29M 14.6% down
2019$124.40M 108.8% up
2018$59.58M 96.1% up
2017$30.39M 60.7% up
2016$18.91M 58.9% up
2015$11.90M 79.1% up
2014$6.65M 17.5% down
2013$8.06M 23.5% up
2012$6.52M 33.1% up
2011$4.90M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of TG Therapeutics and comparable companies
CompanyTotal liabilitiesFiscal year
Madrigal Pharmaceuticals MDGL$656.90M2025
Henry Schein HSIC$6.42B2025
Oscar Health OSCR$5.34B2025
TG Therapeutics TGTX$415.23M2025
Praxis Precision Medicines PRAX$59.77M2025
Twist Bioscience TWST$233.79M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TGTX

TG Therapeutics, figure by figure

TG Therapeutics (TGTX) overview: price, valuation and scorecardAll health care companies by market value

TG Therapeutics total liabilities: questions and answers

How large are TG Therapeutics's total liabilities?

TG Therapeutics (TGTX) had total liabilities of $415.23M at the end of fiscal 2025 (December 31, 2025). That is 16.9% higher than the $355.33M of fiscal 2024.

What is the growth rate of TG Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 31.3% a year; over ten years the rate was 42.7% a year.

What are the highest and lowest total liabilities figures on record for TG Therapeutics?

Across the 15 fiscal years on record (2011–2025), the highest was $415.23M in fiscal 2025 and the lowest $4.90M in fiscal 2011.

How is TG Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For TG Therapeutics it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TG Therapeutics (TGTX) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/TGTX/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.